Month: October 2022

Oct 28 2022

Uncategorized

Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating NBI-1117568 in Adults with Schizophrenia

by Clinical Editor

No Comments

Neurocrine Biosciences, Inc. (Nasdaq: NBIX), a leading neuroscience-focused biopharmaceutical company, today announced the first patient has been randomized for its Phase 2 placebo-controlled, …

Oct 27 2022

Uncategorized

Huge unveiling of schizophrenia brain cells show new treatment targets

by Clinical Editor

No Comments

If you thought it was easy to analyze brain cells, think again. When you take a brain tissue sample, all that your analysis would normally show you is an average...

Oct 27 2022

Uncategorized

Patients With Schizophrenia Twice as Likely to Develop Dementia?

by Clinical Editor

No Comments

Patients with psychotic orders are at substantially higher risk of developing dementia, especially those diagnosed with psychosis at an earlier age, new research suggests.

Oct 27 2022

Uncategorized

Genes link bipolar, schizophrenia, once thought unrelated

by Clinical Editor

No Comments

A growing body of research shows that bipolar disorder, schizophrenia and the in-between diagnosis of schizoaffective disorder share common genetic underpinnings.

Oct 27 2022

Uncategorized

Schizophrenia: Is It a Disability?

by Clinical Editor

No Comments

Schizophrenia may make it harder to get, keep, or carry out the responsibilities that come with employment. For some people, schizophrenia can also make it more difficult to take care...

Oct 27 2022

Uncategorized

Rare Coding Variants May Influence Cognition in Schizophrenia

by Clinical Editor

No Comments

Ultrarare constrained variants (URCVs) may contribute to variance in cognition in patients with schizophrenia, according to a study published online Aug. 17 in JAMA Psychiatry. Hugo D.J. Creeth, Ph.D.

Oct 26 2022

Uncategorized

Huge unveiling of schizophrenia brain cells show new treatment targets

by Clinical Editor

No Comments

If you thought it was easy to analyze brain cells, think again. When you take a brain tissue sample, all that your analysis would normally show you is an average...

Oct 26 2022

Uncategorized

Patients With Schizophrenia Twice as Likely to Develop Dementia?

by Clinical Editor

No Comments

Patients with psychotic orders are at substantially higher risk of developing dementia, especially those diagnosed with psychosis at an earlier age, new research suggests.

Oct 26 2022

Uncategorized

Genes link bipolar, schizophrenia, once thought unrelated

by Clinical Editor

No Comments

A growing body of research shows that bipolar disorder, schizophrenia and the in-between diagnosis of schizoaffective disorder share common genetic underpinnings.

Oct 26 2022

Uncategorized

Rare Coding Variants May Influence Cognition in Schizophrenia

by Clinical Editor

No Comments

Ultrarare constrained variants (URCVs) may contribute to variance in cognition in patients with schizophrenia, according to a study published online Aug. 17 in JAMA Psychiatry. Hugo D.J. Creeth, Ph.D.